A review of studies on barriers or facilitators to use of medication assisted treatment (MAT) for opioid use disorder (OUD) from the Veteran’s Health Administrations Evidence Synthesis Program. The use of MAT to treat OUD is an evidence-based practice that is often not implemented in real world settings.
This 2019 report from the Medicaid and CHIP Payment and Access Commission reviews covers Medicaid policies related to medication assisted treatment (MAT) for opioid use disorder.
This 2019 bulletin describes evidence-based practices for providing medication assisted treatment (MAT) for individuals with opioid use disorder and coverage of these treatment by Virginia’s Medicaid program.
This publication presents strategies for incorporating medication assisted treatment (MAT) into treatment courts.
This web-based opioid prevention toolkit from Oregon Health Authority’s Heal Safely campaign is intended to be used by community health workers and public health officials to help communities find safe non-opioid options for healing safely and addressing pain.
The U.S. Department of Health and Human Services has prioritized expanding access to medication assisted treatment (MAT) for opioid use disorder (OUD) as an evidence-based treatment. Because many individuals with OUD are Medicaid beneficiaries, this U.S. Governmental Accountability Office report looked at state Medicaid policies and state and federal laws that might act as a barrier to Medicaid patients accessing MAT.
This patient education guide prepared by the College of Psychiatric and Neurologic Pharmacists explains medication assisted treatment for opioid use disorder. Funding Source: College of Psychiatric and Neuerologic Pharmacists
The Association for Community Affiliated Plans, which represents insurers that work with low income and vulnerable individuals, prepared this report on strategies health plans can adopt to increase the number of primary care providers willing to prescribe medications to treat opioid use disorder.
This one page infographic from the National Institute on Drug Abuse shows the occurrence of neonatal withdrawal syndrome (also known as neonatal abstinence syndrome) in babies born in the United States between 2004 and 2014.
This 2019 publication by SAMHSA discusses the challenges to providing medication assisted treatment in criminal justice settings such as correctional facilities, reentry programs, and treatment courts and provides policy makers with strategies to overcome these challenges. Funding Source: Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services